Belle Mead, NJ, United States of America

Dina Vogt

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Sanofi. Active years: 2026.

USPTO Granted Patents = 1 

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Dina Vogt: Innovator in Wearable Health Technology

Introduction

Dina Vogt is a prominent inventor based in Belle Mead, NJ (US). She has made significant contributions to the field of medical technology, particularly in the area of wearable health monitoring devices. Her innovative approach aims to enhance the efficacy of medical treatments through advanced monitoring techniques.

Latest Patents

Dina Vogt holds 1 patent for her invention titled "Evaluating drug efficacy by using wearable sensors." This patent outlines methods and systems designed to determine the effectiveness of medical treatments by monitoring biomarkers of patients during their normal daily activities. The wearable sensors can be conveniently attached to the patient in various forms, such as a watch, headband, or belt, allowing for continuous and unobtrusive monitoring.

Career Highlights

Dina is currently employed at Sanofi, a global healthcare company dedicated to improving health and well-being. Her work at Sanofi focuses on integrating innovative technologies into healthcare solutions, making a significant impact on patient care.

Collaborations

Dina collaborates with talented professionals in her field, including Elias Abou Zeid and Hillol Sarker. These partnerships enhance her research and development efforts, fostering a collaborative environment that drives innovation.

Conclusion

Dina Vogt's contributions to wearable health technology exemplify the potential of innovation in improving medical treatment efficacy. Her work continues to pave the way for advancements in patient monitoring and healthcare solutions.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…